Bruker Co. (NASDAQ:BRKR) Shares Purchased by Congress Asset Management Co. MA

Congress Asset Management Co. MA boosted its stake in Bruker Co. (NASDAQ:BRKRFree Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,414,362 shares of the medical research company’s stock after buying an additional 47,301 shares during the period. Congress Asset Management Co. MA’s holdings in Bruker were worth $132,865,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in BRKR. Citigroup Inc. increased its position in Bruker by 1.9% in the third quarter. Citigroup Inc. now owns 59,047 shares of the medical research company’s stock worth $3,679,000 after buying an additional 1,079 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Bruker during the third quarter valued at $845,000. Envestnet Asset Management Inc. increased its holdings in shares of Bruker by 78.6% during the third quarter. Envestnet Asset Management Inc. now owns 193,228 shares of the medical research company’s stock valued at $12,038,000 after purchasing an additional 85,012 shares during the period. Invesco Ltd. increased its holdings in shares of Bruker by 3.0% during the third quarter. Invesco Ltd. now owns 1,950,145 shares of the medical research company’s stock valued at $121,494,000 after purchasing an additional 56,869 shares during the period. Finally, Clear Street Markets LLC acquired a new position in shares of Bruker during the third quarter valued at $50,000. 79.52% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

BRKR has been the topic of a number of research analyst reports. Stifel Nicolaus lowered their price target on Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. Jefferies Financial Group initiated coverage on Bruker in a report on Monday, June 3rd. They set a “buy” rating and a $85.00 price target on the stock. The Goldman Sachs Group raised their price target on Bruker from $66.00 to $74.00 and gave the company a “sell” rating in a report on Wednesday, April 10th. Bank of America decreased their target price on Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, May 20th. Finally, StockNews.com cut Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.00.

Check Out Our Latest Research Report on BRKR

Bruker Trading Down 0.8 %

Shares of NASDAQ:BRKR traded down $0.52 during midday trading on Friday, reaching $66.02. The company had a trading volume of 1,591,703 shares, compared to its average volume of 1,357,399. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.91 and a current ratio of 1.81. Bruker Co. has a 1-year low of $53.79 and a 1-year high of $94.86. The firm has a market cap of $9.60 billion, a price-to-earnings ratio of 24.01, a price-to-earnings-growth ratio of 2.50 and a beta of 1.25. The company has a fifty day simple moving average of $73.24 and a two-hundred day simple moving average of $77.48.

Bruker (NASDAQ:BRKRGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The medical research company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.07. Bruker had a return on equity of 27.31% and a net margin of 13.38%. The business had revenue of $721.70 million during the quarter, compared to analyst estimates of $729.88 million. During the same quarter last year, the company posted $0.64 EPS. Bruker’s revenue for the quarter was up 5.3% on a year-over-year basis. Research analysts predict that Bruker Co. will post 2.66 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 17th. Investors of record on Monday, June 3rd were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s dividend payout ratio is currently 7.27%.

Bruker Company Profile

(Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Featured Articles

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKRFree Report).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.